[1]
M. A. Ghodsirad, “Diagnostic Utility of Lutetium-177 (Lu 177) Prostate-Specific Membrane Antigen (PSMA) Scintigraphy In Prostate Cancer Patients With PSA Rise And Negative Conventional Imaging”, Urol J, vol. 17, no. 4, pp. 374–378, Jun. 2020.